CompuCyte Gains New Ground in Academia, But Will Pharma Remain Interested in i Series Cytometers? | GenomeWeb

WOODBURY, NY — CompuCyte has placed at least six of its 'i' Series imaging cytometers at various academic and research institutes over the past 12 months, including one of its newest instruments launched earlier this year, a CompuCyte executive said this week.

Elena Holden, CompuCyte's president and CEO, disclosed the placements to CBA News during a scientific symposium on quantitative imaging cytometry held by the company at Cold Spring Harbor Laboratory's Genome Research Center, located here.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.